Publications by authors named "Louis Nykamp"

Claim this Profile
D
Depression Remission and Response Rates and Anxiety Response as a Predictor of Depression Response in a Community Electroconvulsive Therapy Clinic.
Sara B VanBronkhorst, Joseph J Keller, Evonne M Edwards, Ali A Saleem, Darci L Evans, Louis Nykamp

Prim Care Companion CNS Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression.
Stephen A Murata, Zachary B Madaj, Colt D Capan, Ryan D Sheldon, Rif S El-Mallakh, Louis J Nykamp

Biol Psychiatry Glob Open Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.
Maria I Lapid, Julia Merrill, Martina Mueller, Adriana P Hermida, Louis Nykamp

PLoS One· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Approach to Monitoring Cognitive Adverse Events for Interventional Studies Involving Advanced Dementia Patients: Insights From the Electroconvulsive Therapy for Agitation in Dementia Study.
Soohyun Park, Brent P Forester, Maria I Lapid, David G Harper, Adriana P Hermida, Louis Nykamp

J Geriatr Psychiatry Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial.
Balwinder Singh, Sagar V Parikh, Jennifer L Vande Voort, Vanessa K Pazdernik, Eric D Achtyes, Louis Nykamp

Psychiatry Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.
Sagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, Eric Achtyes, Fernando S Goes, Louis Nykamp

J Affect Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.
Kaitlin R McManus, Maria I Lapid, Brent P Forester, Martina Mueller, Adriana P Hermida, Louis Nykamp

J ECT· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement.
Maria I Lapid, Stephen Seiner, Hannah Heintz, Adriana P Hermida, Louis Nykamp

Am J Geriatr Psychiatry· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
Deepa Acharya, David G Harper, Eric D Achtyes, Stephen J Seiner, Jack A Mahdasian, Louis J Nykamp

Int J Geriatr Psychiatry· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis